CLDN18 (claudin 18)

2007-09-01  

Identity

HGNC
LOCATION
3q22.3
LOCUSID
ALIAS
SFTA5,SFTPJ
FUSION GENES

Other Information

Locus ID:

NCBI: 51208
MIM: 609210
HGNC: 2039
Ensembl: ENSG00000066405

Variants:

dbSNP: 51208
ClinVar: 51208
TCGA: ENSG00000066405
COSMIC: CLDN18

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000066405ENST00000183605P56856
ENSG00000066405ENST00000343735P56856
ENSG00000066405ENST00000479660F8WEY4

Expression (GTEx)

0
50
100
150
200
250
300
350
400

Pathways

PathwaySourceExternal ID
Cell adhesion molecules (CAMs)KEGGko04514
Tight junctionKEGGko04530
Leukocyte transendothelial migrationKEGGko04670
Cell adhesion molecules (CAMs)KEGGhsa04514
Tight junctionKEGGhsa04530
Leukocyte transendothelial migrationKEGGhsa04670
Hepatitis CKEGGko05160
Hepatitis CKEGGhsa05160
Cell-Cell communicationREACTOMER-HSA-1500931
Cell junction organizationREACTOMER-HSA-446728
Cell-cell junction organizationREACTOMER-HSA-421270
Tight junction interactionsREACTOMER-HSA-420029

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
380601542024Claudin 18.2 expression in digestive neuroendocrine neoplasms: a clinicopathological study.0
387247212024Claudin-18 status and its correlation with HER2 and PD-L1 expression in gastric cancer with peritoneal dissemination.0
387494472024Expression of the membrane tetraspanin claudin 18 on cancer cells promotes T lymphocyte infiltration and antitumor immunity in pancreatic cancer.0
388434462024Molecular SPECT/CT Profiling of Claudin18.2 Expression In Vivo: Implication for Patients with Gastric Cancer.0
380601542024Claudin 18.2 expression in digestive neuroendocrine neoplasms: a clinicopathological study.0
387247212024Claudin-18 status and its correlation with HER2 and PD-L1 expression in gastric cancer with peritoneal dissemination.0
387494472024Expression of the membrane tetraspanin claudin 18 on cancer cells promotes T lymphocyte infiltration and antitumor immunity in pancreatic cancer.0
388434462024Molecular SPECT/CT Profiling of Claudin18.2 Expression In Vivo: Implication for Patients with Gastric Cancer.0
366396222023Claudin18.2 as a potential therapeutic target for primary ovarian mucinous carcinomas and metastatic ovarian mucinous carcinomas from upper gastrointestinal primary tumours.4
367308332023Strong Annexin A10 Expression Supports a Pancreatic Primary and Combined Annexin A10, Claudin 18, and SOX2 Expression Supports an Esophagogastric Origin in Carcinomas of Unknown Primary.1
367931902023Claudin18.2 expression and clinicopathological features in cytology effusion specimens from gastric adenocarcinoma: A comparative study with tissue specimens.3
370463122023FAP-targeted CAR-T suppresses MDSCs recruitment to improve the antitumor efficacy of claudin18.2-targeted CAR-T against pancreatic cancer.10
374873172023Correlation of Claudin18.2 expression with clinicopathological characteristics and prognosis in gastric cancer.0
366396222023Claudin18.2 as a potential therapeutic target for primary ovarian mucinous carcinomas and metastatic ovarian mucinous carcinomas from upper gastrointestinal primary tumours.4
367308332023Strong Annexin A10 Expression Supports a Pancreatic Primary and Combined Annexin A10, Claudin 18, and SOX2 Expression Supports an Esophagogastric Origin in Carcinomas of Unknown Primary.1

Citation

Dessen P

CLDN18 (claudin 18)

Atlas Genet Cytogenet Oncol Haematol. 2007-09-01

Online version: http://atlasgeneticsoncology.org/gene/49740/cldn18-(claudin-18)